Is Mitochondrial Transplantation The Longevity Intervention Of The Future (OLD Mice Climbing Up Walls Like YOUNG Mice!) With Tom Benson of Mitrix
Summary
Ben Greenfield interviews Tom, CEO of Mitrix, about bioreactor-grown mitochondria and mitochondrial transplantation for longevity. They discuss how aging degrades mitochondrial DNA and why standard stem cell therapies are insufficient for systemic rejuvenation. The episode explores Mitrix’s technology for creating young mitochondria from stem cells and their potential to treat diseases and reverse age-related decline.
Topics discussed
Intro, Mitrix guest, and Boundless documentary tour
Mitochondria basics: cellular power plants and history
Mitochondrial DNA damage and the aging process
Why current therapies fail to fix mitochondrial DNA
Bioreactor-grown stem cells and scaling issues
Mitochondrial transplantation and exosome delivery
Clinical trials, safety, and animal study results
Future applications for disease and longevity
The mitochondrial cycle and stress impact
Mitelets vs. exosomes and testing challenges
Mitoclock urine test and biological age
Conclusion, resources, and FTC disclaimer
Listen ad-free on Castria